Clinical Trial Update: A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase I/II clinical trial evaluating S-1 in combination with weekly docetaxel for metastatic gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Stomach Neoplasms | Phase 1, Phase 2 | Status: COMPLETED